PlateletBio
Phil is a venture partner at Third Rock Ventures and has served as Chief Medical Officer of Goldfinch Bio, co-founder of Fulcrum Therapeutics, co-founder and Chief Medical Officer of Voyager Therapeutics, Chief Medical Officer of Bluebird Bio, co-founder of Edimer, among other startup roles. He served as Chairman and CEO of Interleukin Genetics. He earned his medical degree at the Yale School of Medicine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
PlateletBio
PlateletBio is the only allogeneic cell therapy company focused on platelet biology. The company's approach is one-of-a-kind, recreating nature’s legendary delivery cell. In doing so, they're developing a superior cell therapy empowered to tackle previously unmet medical challenges.